comparemela.com

Latest Breaking News On - குறுகிய வடிவம் ஆரோக்கியம் கணக்கெடுப்பு - Page 1 : comparemela.com

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial News provided by Share this article Share this article 1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathyroid hormone). 2. PaTHway China Trial is designed to assess the potential of TransCon™ PTH as a hormone replacement therapy, and the aim is to enable patients to have serum calcium (sCa) within the normal range and independence from usual care.

Empathic Phone Calls Reduce Depression and Anxiety in Older Adults Amid the Pandemic

Empathic Phone Calls Reduce Depression and Anxiety in Older Adults Amid the Pandemic A new study finds that layperson-delivered phone calls reduced loneliness, depression, and anxiety during the COVID-19 lockdown. 72 One major risk factor for mental health disorders, loneliness, has massively increased during the COVID-19 pandemic. A new study, published in JAMA Psychiatry, reports on a randomized clinical trial of an empathy-oriented telephone program delivered by lay-callers (non-mental health professionals) to older adults receiving services through a Meals on Wheels organization. The study found a significant, rapid reduction in loneliness, depression, and anxiety. The lead researcher, Maninder K. Kahlon from Dell Medical School at The University of Texas, writes:

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.